Advances in Key Drug Target Identification and New Drug Development for Tuberculosis.
Tuberculosis (TB) is a severe infectious disease worldwide. The increasing emergence of drug-resistant Mycobacterium tuberculosis (Mtb) has markedly hampered TB control. Therefore, there is an urgent need to develop new anti-TB drugs to treat drug-resistant TB and shorten the standard therapy. The d...
| Published in: | BioMed Research International pp. 1 - 24 |
|---|---|
| Main Authors: | , , |
| Format: | pictorial review tables/charts Journal Article |
| Published: |
Wiley-Blackwell
2/25/2022
|
| Online Access: | View this record in EBSCOhost |